Insulin is one of the standard components used to culture primary neurospheres. Although it stimulates growth of different types of cells, the effects of insulin on adult neural stem cells (NSCs) have not been well characterized. Here, we reveal that insulin stimulates proliferation, but not survival or self-renewal, of adult NSCs. This effect is mediated by insulin receptor substrate 2 (IRS2) and subsequent activation of the protein kinase B (or Akt), leading to increased activity of the G1phase cyclin-dependent kinase 4 (Cdk4) and cell cycle progression. Neurospheres isolated from Irs2-deficient mice are reduced in size and fail to expand in culture and this impaired proliferation is rescued by introduction of a constitutively active Cdk4 (Cdk4 R24C/R24C ). More interestingly, activation of the IRS2/Akt/Cdk4 signaling pathway by insulin is also necessary for the generation in vitro of neurons and oligodendrocytes from NSCs. Furthermore, the IRS2/Cdk4 pathway is also required for neuritogenesis, an aspect of neuronal maturation that has not been previously linked to regulation of the cell cycle. Differentiation of NSCs usually follows exit from the cell cycle due to increased levels of CDK-inhibitors which prevent activation of CDKs. In contrast, our data indicate that IRS2-mediated Cdk4 activity in response to a mitogen such as insulin promotes terminal differentiation of adult NSCs. STEM CELLS 2017;35:2403-2416 
INTRODUCTION
Adult stem cells balance self-renewal with the continual production of differentiating progeny to sustain physiological cell turnover throughout life. They reside in specific microenvironments or niches where interactions with other cells or extracellular matrix molecules as well as diverse soluble signals are critical determinants of their behavior [1] . In the mammalian brain, ongoing production of neurons and oligodendrocytes supported by neural stem cells (NSCs) continues after birth in two restricted germinal areas: the subgranular zone of the dentate gyrus which produces interneurons that become integrated within the same structure and the ventricular-subventricular zone (V-SVZ; also called subependymal zone) in the walls of the lateral ventricles which generates olfactory bulb interneurons and corpus callosum oligodendrocytes [2] [3] [4] . Adult NSCs of the V-SVZ, also known as B cells, are quiescent radial glia/astroglia-related cells that express glial fibrillary acidic protein (GFAP). When activated, they give rise to transit amplifyingneural progenitors which divide rapidly a [3] . In the presence of epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2), individual cells isolated from the V-SVZ niche can be induced to proliferate in vitro and form floating clonal colonies of cells called "neurospheres" [5] . Neurosphere analysis allows the quantification of the self-renewing and multilineage potency capacities of these cells as well as the identification of signaling mechanisms which sustain these properties [6] .
Insulin and insulin-related growth factors (IGFs) stimulate the proliferation of different fetal, postnatal, and adult neural progenitors (NPs) and NSCs [7] [8] [9] [10] [11] [12] [13] (see ref. 14 for a review). The cellular actions of insulin, IGF-I, and IGF-II are mediated by tyrosine kinase membrane receptors which include the insulin receptor isoforms (IR-A and IR-B), the hybrid receptor, and the IGF-I receptor (IGF-1R). In addition, IGF-II can bind the IGF-2R/ mannose-6-phosphate receptor, a transmembrane receptor with no kinase activity [14] . Activation of IR/IGF-1R results in phosphorylation of insulin receptor substrate (IRS) proteins which act as docking sites for various signaling molecules including the p85 regulatory subunit of phosphoinositide-3-kinase (PI3K) [15, 16] . IRS1 and IRS2 are widely expressed and mediate IGF-I and insulin actions in most tissues, whereas IRS3 is restricted to adipose tissue and IRS4 is primarily detected in the brain [17] [18] [19] [20] [21] [22] . Deletion of the Irs1 gene in mice causes overall growth retardation [23, 24] . In contrast, Irs2-knockout mice reach normal body weight at term, but display reduced brain size due to impaired proliferation of NPs during embryogenesis [25, 26] . IRS2 signals modulate synaptic transmission in the hippocampus [27] [28] [29] but the role of this molecule in the regulation of adult NSC/NPs remains unknown.
Cell cycle progression relies on the phosphorylation of the retinoblastoma protein (pRb) by G1 cyclin-dependent kinases (CDK), Cdk4/6 and Cdk2, in association with their corresponding partners, D-and E-type cyclins. In response to mitogenic stimuli, CDK-dependent phosphorylation of pRb results in the physical release of transcription factor E2F from the pRb-E2F complex and subsequent E2F-dependent transcription of genes necessary for promoting S-phase entry [30] . In different types of NSC/NPs, insulin activates protein kinase B (also known as Akt) to increase levels of cyclin D1 and/or reduce levels of CDK inhibitors (CKI) p57 and p27 [11, 13, [31] [32] [33] . Interestingly, specific CDKs have been found in the brain to regulate events beyond cell cycle, such as E2F-independent transcription, DNA damage repair, cell death, metabolism, neuronal migration, axonal elongation, and synaptic maturation and plasticity [34, 35] . Here, we report that insulin regulates adult NSC proliferation through an IRS2/Akt/Cdk4 signaling pathway in vitro. In addition, our studies demonstrate that this same mechanism promotes differentiation and neuritogenesis, a final aspect of neuronal differentiation.
MATERIALS AND METHODS

Animals
Generation and genotyping of Irs2 knockout (C57Bl6 background) and Cdk4 R24C/R24C knockin (129/Sv background) mice have been described previously [25, 36] . They were maintained and bred at the Centro de Investigaci on Pr ıncipe Felipe (CIPF) animal core facility in accordance with Spanish RD53/ 2013 guidelines, following protocols approved by the CIPF and Universidad de Valencia institutional committees on experimental research. For bromodeoxyuridine (BrdU) labeling, mice received seven intraperitoneal (i.p.) injections of 50 mg/g body weight BrdU, one every 2 hours, and were killed 1 hour after the last injection.
Histological Technique and Immunohistochemistry
Mice were anesthetized (225 mg/kg ketamine and 3 mg/kg medetomidine) and transcardially perfused with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB) pH 7.4. The brains were dissected and postfixed by immersion in the same fixative overnight (o/n), washed in PB for 2 hours, dehydrated, and embedded in paraffin. Seven micron-thick coronal sections were blocked using 10% fetal bovine serum (FBS) and 0.2% Triton X-100 in PB (blocking buffer). For BrdU immunodetection, sections were first treated with 2N HCl for 15 minutes at 378C and neutralized in 0.1 M borate buffer (pH 8.5) for 10 minutes. Blocked sections were incubated o/n at 48C with rat anti-BrdU (1:600, Abcam, Cambridge, UK), chicken anti-GFAP (1:400, Sigma-Aldrich, St. Louis, Missouri, US), and goat anti-Sox2 (1:50, R&D, Minneapolis, Minnesota, US), or anti-doublecortin (DCX) (1/200; Santa Cruz Biotechnology, Dallas, Texas, US) antibodies diluted in blocking buffer. After several PB washes, the sections were incubated for 1 hour at room temperature with Dylight 549-, Dylight 488-, or Cy3-conjugated appropriate secondary antibodies (1:600 to 1:1,500) from Jackson ImmunoResearch Laboratories (West Grove, Pennsylvania, US). Samples were counterstained with Topro or Sytox (Molecular Probes, Eugene, Oregon, US) at 1 mg/ml and mounted with Fluorsave (Calbiochem, San Diego, California, US). Images were captured using a Fluoview FV10i (Olympus, Tokyo, Japan) confocal microscope. Volume measurements were obtained using Scion Image software in one every seventh section in complete series stained with hematoxylin-eosin.
NSC Culture and Immunocytochemistry
Methods for adult neurosphere culture and analysis have been described previously [6, 37] . For differentiation, individual cells were plated on Matrigel-coated glass coverslips (40,000 cells per square centimeter) and cultured for 2 days in control medium containing 10 ng/ml of FGF2 to first promote their expansion. Then, the medium containing FGF2 was replaced by control medium supplemented with 2% of heat-inactivated FBS for 5 more days to allow for a complete differentiation. Cells were treated with 100 nM of the Cdk4 inhibitor 2-bromo-12,13-dihydro-5Hindolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione or with 30 mM of the Akt inhibitor LY294002 (Calbiochem, San Diego, California, US). For BrdU analysis in neurospheres, suspensions of dissociated cells at a 25 cell per microliter density were cultured for 24 hours in growth medium with 2 mM BrdU and the spheres formed were seeded onto poly-L-lysine coated glass coverslips. During differentiation, 2 mM BrdU was added to the cells 5 minutes before fixation. Cultures were fixed with 4% PFA in PB for 20 minutes, rinsed three times in PB, incubated for 30 minutes in blocking buffer and with the following primary antibodies o/n at 48C: rabbit anti-GFAP (1:200; Dako, Glostrup, Denmark) or anti-Olig2 (1:300, Millipore, Billerica, Massachusetts, US), mouse anti-bIII-tubulin (clone Tuj1; 1:300; Covance, Princeton, New Jersey, US), anti-Mash1 (1:100, BD, Biosciences, Franklin Lakes, New Jersey, US) or anti-Nestin (1:3, rat401 supernatant, Developmental Studies Hybridoma Bank, DSHB, Iowa City, Iowa, US), and rat anti-O4 (1:3; Developmental Studies Hybridoma Bank, DSHB, Iowa City, Iowa, US). For BrdU detection, the coverslips were treated with 2 N HCl for 15 minutes, neutralized in 0.1 M borate buffer (pH 8.5), before the incubation for 90 minutes at 378C with mouse anti-BrdU antibodies (1:250; Dako, Glostrup, Denmark) in blocking buffer. Following several washes, cells were incubated with appropriate fluorescently (Cy2 or Cy3)-labeled secondary antibodies (1:500; Jackson ImmunoResearch Laboratories, West Grove, Pennsylvania, US) in blocking buffer for 45 minutes, rinsed several times in PB, counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI) at 1 mg/ml, and mounted with Fluorsave.
Protein Isolation/Western Blotting
Approximately 750,000 cells were harvested from 3-day grown neurospheres and subsequently homogenized in lysis buffer [20 mM phosphate buffer saline, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 2.5 mM sodium orthovanadate, 20 mM sodium fluoride, 2 mM phenyl-methane-sulfonylfluoride, and 1X Complete Mini tablet (Roche, Basel, Switzerland)] for 20 minutes, and centrifuged at 20,000g for 15 minutes at 48C. Protein concentration was determined by Pierce BCA Protein assay kit (Thermo Fisher Scientific, Waltham, Massachusetts, US). Protein extracts (50-100 mg) were denatured in Laemmli's sample buffer containing b-mercaptoethanol, SDS, and bromophenol blue, separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocelulose membranes (Sigma-Aldrich, St. Louis, Missouri, US). For immunoprecipitation of IRS proteins, neurospheres were homogenized in lysis buffer [20 mM Tris-HCl, pH 7.6, 10% glycerol, 1% NP-40, 137 mM NaCl, 2 mM EDTA, 1 mM sodium orthovanadate, and 1 mM phenylmethylsulfonyl fluoride] and 500 mg of protein lysates were immunoprecipitated with antibodies to either IRS1 or IRS2 [25] and protein A-sepharose beads. Beads were boiled in SDS sample buffer, separated on 8% SDS-PAGE, and transferred as described previously [25] . Membranes were blocked 1 hour at room temperature with 5% non-fat dry milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T) and incubated with rabbit anti-AktPS473 (1:500, Cell Signaling Technology, Danvers, Massachusetts, US), anti-p85 (Withers et al., 1998) , anti-p44/42 MAPK (Erk1/2/) (1:1,000 Cell Signaling Technology, Danvers, Massachusetts, US), or anti-phosphoRb (Ser807/811) (1:1,000, Cell Signaling Technology, Danvers, Massachusetts, US), goat anti-Akt (1:100, Santa Cruz Biotechnology, Dallas, Texas, US), and mouse antiphosphotyrosine antibodies (1:1,000, Upstate Biotechnology, Lake Placid, New York, US), anti-phospho p44/42 MAPK (Erk1/ 2) (Thr202/Tyr204) (1:2,000, Cell Signaling Technology, Danvers, Massachusetts, US), anti-Rb (1:200, Santa Cruz Biotechnology, Dallas, Texas, US), or anti-GAPDH (1:500, Sigma-Aldrich, St. Louis, Missouri, US) antibodies in blocking buffer, o/n at 48C. The rabbit antibodies against IRS1, IRS2, and IRS4 were a generous gift of Dr. Morris White (Children's Hospital, Boston). After extensive washing with TBS-T, membranes were incubated for 1 hour at room temperature with horseradish peroxidase-conjugated antibodies to mouse (1:1,000, Dako, Glostrup, Denmark), rabbit (1:25,000, Amersham), or goat (1:1,000, Dako, Glostrup, Denmark) IgGs in blocking buffer. Peroxidase activity was developed using Western Lightning Plus reagents (Perkin Elmer, Waltham, Massachusetts, US) according to supplier recommendations.
Statistical Analysis
All values are represented as the mean 6 SEM. For each experiment, the number of independent cultures/animals is indicated as "n." Differences among means were calculated using Student's t test or repeated measures analysis of variance with Tukey's post hoc test. For relative values, the arcsin transformation was applied to the data to obtain normally distributed values. Significance was set at: *, p < .05; **, p < .01; ***, p < .001. Statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS) software, v18.
RESULTS
Proliferative Effects of Insulin/IGFs on Adult NSCs Are Mediated by IRS2
Culture media used to grow neurospheres typically contain supra-physiological concentrations of insulin (from 1 to 4.4 mM), in addition to mitogens EGF and/or FGF2 in the nanomolar range [14, 37] . Although the growth-stimulating effects of insulin in cultures of NSC/NPs isolated from fetal and early postnatal brains are well known [12, 33] , the effects of insulin and its signaling pathways on adult NSCs have not been analyzed extensively. We observed that increasing concentrations of insulin enhanced both the numbers and size of neurospheres in V-SVZ cultures. This effect was noted at 10 nM, reaching a maximum effect at 100 nM ( Fig. 1A, 1B ). Insulin activates the IR at physiological concentrations (25 ng/ml or 4.4 nM), but can also act through related receptors at higher concentrations [14, 38] . Conversely, given structural similarity of the receptors, IGFs at higher concentrations can also activate the insulin receptor, even though IGF-I and IGF-II generally display a low affinity for the IR. Our analysis revealed that neurospheres express mRNAs for IR-A and IR-B as well as the IGF-1R and IGF-2R ( Fig. 1C ; see also ref. 39 ) and, therefore, insulin at 10 nM or above could act in these cells via its own and/or these other receptors. Consistent with this possibility, our data indicated that insulin, IGF-I or IGF-II at a concentration of 10 nM or greater stimulated neurosphere proliferation to a similar extent ( Fig. 1D ). Moreover, combining all three mitogens failed to produce an additive response, suggesting that these factors activate the same intracellular signaling pathways.
Activation of insulin/IGF receptors results in the phosphorylation of IRSs; IRS1 and IRS2 are ubiquitously expressed and mediate insulin actions in most tissues [17, 18, 40, 41] . Immunoprecipitation and subsequent Western blotting revealed the presence of IRS1 and IRS2, but not IRS4 in V-SVZ homogenates ( Fig. 1E ). To assess the role of IRS signaling, NSCs were cultured during 48 hours and subsequently starved of mitogens for 6 hours, followed by 10 minutes stimulation with insulin/IGFs and lysates were immunoprecipitated with antibodies against IRS1 or IRS2. Stimulation with insulin, IGF-I or IGF-II (10 nM), activated IRS2 and to a lesser extent IRS1 as detected by anti-phosphotyrosine antibodies. Consistent with this, Western blots revealed that, the PI3K regulatory subunit p85a was preferentially detected in immunoprecipitates of IRS2 rather than IRS1, suggesting that IRS2 mediates in vitro effects of insulin and IGFs on NSCs (Fig. 1F) .
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Addition of any of these factors to single NSCs significantly increased the numbers of incipient clones (four or more cells) within 24 hours of plating ( Fig. 2A ). Quantification of FITC-Annexin V-positive/propidium iodide-negative apoptotic cells revealed no significant differences in treated versus untreated cultures (EGF/FGF2, 20 6 6; 1insulin, 15 6 5; 1IGF-I, 19 6 9; 1IGF-II, 18 6 4; n 5 4), suggesting that positive effects of insulin/IGFs on neurosphere-initiating cells are not due to prosurvival effects. In agreement with a proliferation-stimulating effect, neurospheres grown for 5 days in insulin or IGFs were larger (mean Immunodetection of the different IRS proteins in ventricular-subventricular zone homogenates. A 500-lg protein lysate was immunoprecipitated with specific antibodies followed by immunoblotting with the same antibodies, as indicated. As an input control, total homogenates were separated by SDS-polyacrylamide gel electrophoresis and probed by Western blot using an antibody against the p85a subunit of phosphoinositide-3-kinase (PI3K). (F): Immunodetection of phosphotyrosine (PY) and the PI3K regulatory subunit p85a following immunoprecipitation with antibodies specific for IRS1 and IRS2 in neurosphere dissociates stimulated for 10 minutes with 10 nM of the indicated factors. Unstimulated cells were used as a negative control and cells treated with fetal calf serum as a positive control. p value: ***, p < .001. Scale bar 5 100 mm (B). Abbreviations: FCS, fetal calf serum; IGF, insulin-related growth factor; IRS, insulin receptor substrate; NSC, neural stem cell; V-SVZ, ventricular-subventricular zone. IGFs do not modify self-renewal when present, but promote neurosphere formation through actions on proliferation.
To assess the potential role of IRS2, we analyzed NSCs isolated from Irs2-deficient mice [25] . Neonatal Irs2 mutant mice exhibit normal body size, but are born with significantly smaller brains (Fig. 2C) owing to impaired neuronal development in utero [26] . Consistently, fewer primary neurospheres were obtained from the V-SVZ of two-month old mutants (data not shown). We then plated equal numbers of passage (P) 1 neurosphere cells from wild-type and Irs2-deficient neurospheres and expanded them during several passages. Mutant cultures displayed reduced expansion, reduced neurosphere diameters, and accelerated exhaustion (Fig. 2D, 2E) indicating that IRS2 mediates the growth-promoting action of insulin in adult neurosphere cultures.
We next examined the V-SVZ of adult Irs2 mutants. The number of GFAP 1 Sox2 1 NSCs, DCX 1 neuroblasts and cells that incorporated BrdU (seven injections over a 12 hour-interval) were all reduced ( Fig. 2F-2H ) in these mice. However, cell densities were similar between the two genotypes: no differences were identified in the numbers of GFAP 1 Sox2 1 NSCs relative to Topro 1 nuclei (5.0 6 0.3 vs. 5.2 6 0.7%, n 5 4), or the densities (in cells 3 10 23 per square micrometer) of DCX 1 neuroblasts (4.3 6 0.1 vs. 3.9 6 0.2, n 5 4) or BrdU 1 cells (1.9 6 0.2 vs. 1.8 6 0.2, n 5 5). Moreover, the proliferation rates of GFAP 1 and DCX 1 cells were not affected by the deletion of Irs2 (BrdU-labeling index in GFAP 1 cells: 24.5 6 1.5 vs. 23.5 6 1.5 in wild-type vs. mutant mice, n 5 5; in DCX 1 neuroblasts: 11.5 6 0.5 vs. 11.6 6 0.8 in wild-type vs. mutant mice, n 5 4). These results indicated that defects that underlie the reduction in neuroblasts occur during fetal development. Although IRS2 may not be required for in vivo proliferation in the V-SVZ, the mitogenic effects of insulin on neurosphere cultures in vitro appear to be mediated by IRS2.
Insulin/IRS2 Signaling Stimulates Cdk4 Activity for Cell-Cycle Progression
Activation of IRS proteins leads to subsequent engagement of the PI3K/Akt and/or the Ras-related MAPK cascades [16, 41] . Similar to effects of IGF-I on adult rat NSCs [32, 42] , treatment of neurospheres with 100 nM insulin increased the levels of phosphorylated Akt without changing the levels of phosphorylated ERK1/2 (Fig. 3A) . Consistent with this, 30 mM of the PI3K pharmacological inhibitor LY294002 blocked the effects of insulin on neurosphere diameter and number (Fig.  3B, 3C ). Mitogens, acting through Akt, induce the expression of D-cyclins which are required by Cdk4 or Cdk6 to phosphorylate pRb during early G1 [30] . Treatment of adult neurospheres with 100 nM insulin for 30 minutes resulted in increased phosphorylation of pRb on serine 807/811, a residue which is a direct substrate of Cdk4 kinase activity and the increase was significantly reduced by the addition of 30 mM LY294002 (Fig. 3D ). Furthermore, the levels of phosphorylated pRb were dramatically reduced in IRS2-deficient neurospheres (Fig. 3E ), suggesting a regulation of pRb by an insulin-IRS2-PI3K-Akt-Cdk4 pathway.
Considering the above data, we decided to test the implication of Cdk4 in the effects of insulin. As Cdk4 activity is specifically inhibited by members of the INK4 family of CKIs (p15, p16, p18, p19), we crossed the Irs2 mutant strain with a line of knockin-in mice where the endogenous Cdk4 gene had been replaced with a Cdk4 sequence carrying the oncogenic R24C point mutation (replacement of Arg24 by a Cys) which renders the kinase insensitive to INK4 inhibition [36] . We obtained more primary neurospheres from Cdk4 R24C/R24C V-SVZs (690 6 58 vs. a wild-type value of 416 6 25, n 5 3; p < 0.01) and these were larger in diameter (in micrometer: 67.2 6 3.8 vs. a wild-type value of 55.7 6 2.5, n 5 3; p < 0.05), consistent with the positive role of Cdk4 on proliferation. However, these primary neurospheres did not produce more secondary neurospheres (data not shown) suggesting that the R24C mutation conferred a proliferative advantage to NSCs but, like insulin, did not affect selfrenewal. We next evaluated whether Cdk4 was part of the IRS2-mediated signaling in neurosphere cultures. Phosphorylation levels of pRb were diminished in Irs2 2/2 but not in Irs2 2/2 ;Cdk4 R24C/R24C NSCs (Fig. 3E) , indicating a recovery of activity by the R24C point mutation. Consistent with this observation, both the number and the size of secondary neurospheres of Irs2-deficient cells were rescued by Cdk4 R24C/R24C (Fig. 3F, 3G ). In summary, the absence of IRS2 signals in NSCs could be overcome by the constitutive activation of Cdk4 indicating that pro-proliferative effects of insulin on adult neurospheres are mediated by IRS2/Akt-dependent activation of Cdk4.
The compound mutants allowed us to test whether fetal deficits resulting from the elimination of IRS2 were also dependent on Cdk4. Remarkably, the R24C mutation did not rescue the reduced brain size of Irs2 mutants (wet weight in g: Irs2 1/1 , 0.49 6 0.03, n 5 6; Irs2 2/2 , 0.31 6 0.02, n 5 3; Cdk4 R24C/R24C , 0.48 6 0.03, n 5 3; Irs2 2/2 ;Cdk4 R24C/R24C , 0.32 6 0.04, n 5 6). In agreement with this, primary neurosphere yield was not rescued by the knock-in either (Irs2 1/1 , 428 6 32; Irs2 2/2 , 226 6 18; Cdk4 R24C/R24C , 587 6 35; Irs2 2/2 ; Cdk4 R24C/R24C , 187 6 25, n 5 3).
Insulin Regulates Differentiation and Neuritogenesis Through the IRS2/Akt/Cdk4 Pathway
Insulin/IGFs promote the differentiation of fetal and neonatal NSC/NPs via activated Akt [43, 44] but the role of the IRS2 pathway in the differentiation process of adult NSCs has not been defined. In our differentiation protocol (Fig. 4A ), disaggregated neurosphere cells are plated on Matrigel and cultured for 2 days in control medium (with the regular 3.5 mM insulin) containing FGF2 to allow the expansion of NPs. Subsequently, FGF2 is replaced by 2% FBS and cells are allowed to fully differentiate for 5 more days into the three characteristic neural lineages [6, 45] . The initial phase in FGF2 promotes the expansion of neuronal and oligodendroglial progenitors; afterward, addition of serum causes astrocytes to expand dramatically and become prominent in the culture. During the first 48 hours, insulin increased overall cell proliferation, as reflected in the number of cells present at different times (Fig. 4B, 4C ). Direct measurements of BrdU-labeling rates in Nestin 1 cells indicated that insulin increased the proliferation of adult NPs (Fig. 4D) , without affecting the percentage of caspase 3 1 cells (relative to DAPI 1 cells, 4.9 6 0.7% with insulin and 4.3 6 0.2% without insulin, n 5 3). To evaluate potential effects of insulin on specific NPs, the proportions of cells that were positive for basic helix-loop-helix (bHLH) transcription factor Mash1 (also known as Ascl1), Olig2, or doubly positive for both were determined by immunostaining with specific antibodies. After 2 days in FGF2, around 40% of all cells were positive for both Mash1 and Olig2. However, the presence of insulin did not significantly alter the percentage of Mash1 1 , Olig2 1 , or Mash1/Olig2-doubly positive cells (Fig. 4E) .
We then analyzed the effect of insulin on fully differentiated cultures. After 7 days, cells were fixed and immunostained for GFAP, bIII-tubulin, and O4 as surrogate markers for astrocytes, neurons, and oligodendrocytes, respectively. The percentage of oligodendrocytes and neurons, but not of astrocytes, was significantly reduced in the absence of insulin, whereas increasing concentrations of insulin stimulated their differentiation in a dose-dependent manner (Fig. 5A, 5B) . Stimulation for 10 minutes with insulin activated phosphorylation of Akt (p-Akt/Akt relative levels: 0.51 6 0.03 in insulintreated cultures vs. 0.29 6 0.03 in controls, n 5 3), but not ERK (Fig. 5C) . Moreover, addition of LY294002 reduced proportions of neurons even in the presence of insulin (relative to DAPI 1 cells, 6.1 6 0.4% vs. 10.7 6 0.3% in untreated cultures, n 5 3). The effect of insulin on the differentiation of neurons and oligodendrocytes was dependent on IRS2 activation: even at saturating concentrations, insulin had little or no effect on expression of differentiation markers in Irs2 mutant cultures (Fig. 5D) . Remarkably, the presence of the constitutively active Cdk4 R24C/R24C completely rescued the deficit in neurons and oligodendrocytes found in Irs2 mutant cultures (Fig. 5D ), suggesting the novel concept that IRS2/Akt/Cdk4 pathway also mediates the response to insulin during differentiation.
Effects on differentiation can be difficult to dissociate from effects on cell-cycle withdrawal [46] . Therefore, we next investigated whether insulin/IRS2/Akt/Cdk4 may modulate a terminal differentiation process by evaluating the growth and complexity of the neuritic trees of the differentiated neurons. Fully-differentiated cultures were immunostained for bIIItubulin and the number of neuritic end points determined as an estimate of the branching complexity [47] . Neurons incubated with insulin at either 3.5 mM or 100 nM exhibited well-branched neuritic trees, whereas their complexity declined at lower concentrations of insulin, exhibiting a simple bipolar morphology at 1 nM (Fig. 6A, 6B) . Moreover, addition of LY294002 substantially reduced the number of end-points present in neurons grown in conventional insulin-containing medium (Fig. 6C) .
Irs2 mutant neurons displayed fewer branches even in the presence of insulin (Fig. 6D, 6E) . Interestingly, although the constitutively active Cdk4 transgene did not in and of itself modify neurite complexity, Irs2 2/2 ;Cdk4 R24C/R24C bIII-tubulin 1 cells displayed a normal, well-formed neuritic tree (Fig. 6D,  6E) , indicating that defective neuritogenesis in Irs2 2/2 neurons is also due to reduced Cdk4 activity. Addition of a cellpermeable selective, reversible, and ATP-competitive inhibitor of Cdk4/D1 activity at 100 nM resulted in neurons with fewer dendrites, similar to the impairments observed in the absence of insulin or IRS2 (Fig. 6F, 6G) , indicating that the Cdk4 kinase activity is indeed required for neuritogenesis.
DISCUSSION
Although insulin is a standard component in neurosphere cultures, the precise effects of this hormone on adult NSCs have surprisingly not been defined. The results of the present study indicate that insulin specifically promotes proliferation, but not survival or self-renewal of neurosphere-initiating cells and derived progenitors through the activation of an IRS2/Akt/ Cdk4 pathway. Our data also reveal that insulin is required for the production of oligodendrocytes and neurons and for neuritogenesis during neuronal maturation in vitro. Interestingly, this insulin-mediated neurite sprouting also requires the IRS2/ Cdk4 pathway. Our findings suggest the novel observation that insulin-regulated Cdk4 activity plays a role in the differentiation of adult NSCs and in neuritogenesis.
Proliferation of adult NSC/NPs is stimulated by the addition of mitogens to defined culture media. These media typically contain insulin at relatively high concentrations, ranging from 1 mM in the standard B27 supplement up to 4.4 mM present in some chemically defined neurosphere media [37, 45] (see ref. 14 for a review). These supraphysiological concentrations are around 1,000-fold higher than the circulating levels of insulin required to activate its receptor. Our studies indicate that maximal effects of insulin and related molecules on adult NSC/NPs are achieved at 100 nM. This concentration is sufficient to fully activate IRS2 and Akt and promote proliferation of neurosphere-initiating cells and their derived NPs. Insulin and related factors were unable to activate the proliferation of adult NSC/NPs in the absence of FGF2 or EGF (data not shown), suggesting that they act synergistically with these other mitogens. Based on our data IRS2 rather than IRS1 mediates the required signaling to Cdk4, consistent with the reduced size of the brain in Irs2 but not Irs1 null mice [26] . Interestingly, in the neurosphere cultures, insulin-IRS2 activated Akt but not MAPK. Differential activation of IRS1-versus IRS2-associated signaling complexes has been observed in other cell types: in fibroblasts, specific activation of IRS2 by IGF-I through the insulin receptor does not engage MAPK but does trigger the PI3K/AKT pathway to enhance cell viability [48] . Consistent with this notion of specificity, FGF-2 stimulation of oligodendrocyte progenitors activates the MAPK pathway which promotes cyclin D1 mRNA expression, whereas IGF-I activation of the PI3K pathway inhibits proteasome degradation of cyclin D1 and enhances nuclear localization of cyclin D1 [13, 14, 49] . Thus, insulin and IGFs may selectively use IRS2 in NSCs to regulate Cdk4 via activation of the Akt pathway. This appears to be the case in pancreatic b-cells; IRS2 but not IRS1 is required for expansion of b-cell mass in response to insulin/IGFs and glucose through the activation of the PI3K/Akt pathway [50] . Recently, a new role for Cdk4 as a regulator of insulin signaling has been reported: in adipocytes, Cdk4 phosphorylates IRS2 at serine 388 upon insulin stimulation [51] . However, we did not observe evidence of this positive feedback loop in adult NSCs.
It is well established that insulin/IGFs stimulate the differentiation of different NPs into oligodendrocytes and neurons through Akt activation [7, 9, 43, 44, [52] [53] [54] . We observed similar inductive effects of insulin on V-SVZ cultures, without apparent effects on selective NPs for neuronal and oligodendroglial lineages. Transcription factor Mash1 plays an essential role in oligodendrogenesis as well as neurogenesis. In vivo analyses have demonstrated that Mash1-expressing cells are bipotent progenitors, which in turn generate both oligodendrocytes and neurons [55] [56] [57] [58] . Olig2 is another member of the bHLH family which is essential for oligodendrocyte development and also involved in neurogenesis specification [59] [60] [61] [62] . During the first 2 days of our protocol, insulin did not amplify a specific bipotent progenitor, suggesting that the skewing effect on differentiation may be independent of cell cycle. Our findings reveal the novel observation that insulin signaling pathways also regulate neuritogenesis in the brain, a process that takes places during the maturation of postmitotic neurons. It has been previously shown that IGF-I induces neuritogenesis through the activation of PI3K in peripheral adult sensory neurons [63] , but the potential mechanisms were unknown. Through several strategies, we demonstrate that an intact IRS2/Cdk4 pathway is essential for proper neuritogenesis.
Our genetic experiments indicate that actions of insulin on adult neurospheres ultimately require Cdk4 activity. Expression of the Cdk4 R24C mutant accelerates growth and prevents senescence in mouse embryonic fibroblasts and Cdk4 R24C/R24C mice develop a wide spectrum of tumors [36] . Interestingly, this mutation rescued the impaired proliferation and differentiation caused by Irs2-defeciency in NSCs. Accumulating evidence indicates that the length of G1 in neural precursors plays an important role in the decision to proliferate or to differentiate [46] . In the developing mouse cortex, for example, overexpression of cyclinD/Cdk4 shortens G1 and delays neurogenesis, whereas inhibition by RNAi induces the opposite effect with a lengthening of G1 and an increase in neurogenesis [64] . Studies in the adult mouse hippocampus show that over-expression of the cyclinD/Cdk4 complex increases the expansion of NSC/NPs while inhibiting neurogenesis [65] . However, our findings reveal that Cdk4 activation in response to insulin is required both for proliferation and differentiation/maturation, implicating a more complex scenario for the cell-cycle proteins in these biological processes.
Despite the implication of Cdk4 in the response of cultured neurospheres to insulin, the Cdk4 R24C knock-in did not rescue the reduced brain size in the Irs2 model. Interestingly, pancreatic beta cell mass and function are restored in the compound mutants (D. J. Burks, unpublished results), in line with previous observations that deletion of either Cdk4 or Irs2 impairs beta cell expansion [25, 66] . This interesting difference could be due to the fact that the small brain Chirivella, Kirstein, Ferr on et al. 2413 www.StemCells.com V C AlphaMed Press 2017 phenotype is the result of impaired fetal development, whereas proliferation of pancreatic cells occurs in the adult in response to metabolic demand. Thus, it is plausible that the requirement(s) for the IRS2-Cdk4 pathway may differ in fetal versus adult tissues. Collectively, our data suggest a complex situation where the downstream effects of IRS2 during fetal and early postnatal development of the brain may not depend exclusively on Cdk4 activity. The cyclin D1/Cdk4 complex could regulate proliferation of NSC/NPs through its canonical regulation of E2F. Association of E2F with pRbs facilitates the recruitment of histone deacetylases and methyl-transferases leading to repression of gene transcription. In contrast, pRb phosphorylation by cyclin/CDKs results in the release of E2F and expression of genes required for cell cycle progression [67] . However, it is now generally accepted that E2Fs participate in other processes, including apoptosis, differentiation, metabolism, or mitochondrial function. CDKs also phosphorylate other regulatory molecules. Activation of cyclinD1/Cdk4 by insulin in hepatocytes suppresses gluconeogenesis in a cell cycle-independent manner [68] and Cdk6 has also been shown to regulate transcription factors involved in angiogenesis [69, 70] . Phosphorylation of key neurogenic transcriptional regulators, such as neurogenin 2 or Mash1, by CDKs links prevention of neuronal differentiation to proliferation [71] [72] [73] . In addition, the cyclin D1/Cdk4 complex has been shown to be involved in regulating the phosphorylation of other transcription factors, such as TGFb pathway-dependent Smad3 or FOXM1 [74, 75] . Further studies will be obviously required to further identify the molecular mechanisms targeted by Cdk4 activity in NSCs.
CONCLUSION
Our studies reveal that insulin promotes proliferation and differentiation in adult neurospheres by specifically activating the IRS2/Akt/Cdk4 pathway. These observations are highly relevant as the field of regenerative medicine moves closer to the development of tools to implement stem cell therapy for replacing damaged or lost neurons as a treatment for neurodegenerative diseases. Thus, the insulin signaling pathway may provide a rational strategy to more efficiently generate neurons in vitro and/or to improve the maturation of neuronal progenitors. The novel finding that the IRS2-mediated regulation of Cdk4 activity is essential for neuritogenesis provides new avenues for studying this critical biological process.
